Sami El-Dalati1,2, Venkatesh L Murthy3, Anna B Owczarczyk4, Christopher Fagan5, James Riddell6, Sandro Cinti6, Richard L Weinberg3. 1. Division of Infectious Diseases, Department of Internal Medicine, Michigan Medicine - University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA. seldalat@med.umich.edu. 2. , Ann Arbor, USA. seldalat@med.umich.edu. 3. Division of Cardiovascular Medicine, Department of Internal Medicine, Michigan Medicine - University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA. 4. Department of Pathology, Michigan Medicine - University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA. 5. Department of Internal Medicine, Michigan Medicine - University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA. 6. Division of Infectious Diseases, Department of Internal Medicine, Michigan Medicine - University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.
Abstract
BACKGROUND: Multiple studies have demonstrated that when incorporated with conventional imaging modalities, cardiac F-18 PET/CT can aid in diagnosis of endocarditis and improve the sensitivity of the Duke Criteria. These studies used as their gold standard the opinion of an endocarditis team and were characterized by low percentages of patients who underwent surgery. We reviewed 4 years of surgically managed IE cases where F-18 cardiac PET/CT was used to aid diagnosis. METHODS: Between July 2014 and December 2018, we retrospectively reviewed 68 surgically managed endocarditis cases to identify patients who underwent pre-operative PET scans. RESULTS: Fourteen patients were identified who underwent F-18 cardiac PET/CT prior to surgical intervention. Nine cases were classified as possible endocarditis by Duke Criteria and 8 involved prosthetic valves. Twelve out of fourteen scans were interpreted as suggestive of or consistent with endocarditis based on FDG uptake. Twelve positive PETs were associated with either operative findings of infection and/or positive PCR testing on the excised valve. Two patients with negative scans were found to have non-infectious mobile masses intra-operatively, negative valve cultures and negative pathology. CONCLUSION: In a small cohort, F-18 FDG cardiac PET/CT correlated closely with intra-operative findings in patients with endocarditis and helped guide surgical decision-making. It could be considered for addition to the Duke Criteria in the American Heart Association endocarditis guidelines similar to European protocols.
BACKGROUND: Multiple studies have demonstrated that when incorporated with conventional imaging modalities, cardiac F-18 PET/CT can aid in diagnosis of endocarditis and improve the sensitivity of the Duke Criteria. These studies used as their gold standard the opinion of an endocarditis team and were characterized by low percentages of patients who underwent surgery. We reviewed 4 years of surgically managed IE cases where F-18 cardiac PET/CT was used to aid diagnosis. METHODS: Between July 2014 and December 2018, we retrospectively reviewed 68 surgically managed endocarditis cases to identify patients who underwent pre-operative PET scans. RESULTS: Fourteen patients were identified who underwent F-18 cardiac PET/CT prior to surgical intervention. Nine cases were classified as possible endocarditis by Duke Criteria and 8 involved prosthetic valves. Twelve out of fourteen scans were interpreted as suggestive of or consistent with endocarditis based on FDG uptake. Twelve positive PETs were associated with either operative findings of infection and/or positive PCR testing on the excised valve. Two patients with negative scans were found to have non-infectious mobile masses intra-operatively, negative valve cultures and negative pathology. CONCLUSION: In a small cohort, F-18 FDG cardiac PET/CT correlated closely with intra-operative findings in patients with endocarditis and helped guide surgical decision-making. It could be considered for addition to the Duke Criteria in the American Heart Association endocarditis guidelines similar to European protocols.
Authors: J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey Journal: Clin Infect Dis Date: 2000-04-03 Impact factor: 9.079
Authors: María N Pizzi; Albert Roque; Nuria Fernández-Hidalgo; Hug Cuéllar-Calabria; Ignacio Ferreira-González; María T Gonzàlez-Alujas; Gerard Oristrell; Laura Gracia-Sánchez; Juan J González; José Rodríguez-Palomares; Manuel Galiñanes; Olga Maisterra-Santos; David Garcia-Dorado; Joan Castell-Conesa; Benito Almirante; Santiago Aguadé-Bruix; Pilar Tornos Journal: Circulation Date: 2015-08-14 Impact factor: 29.690
Authors: Sophia R Larson; Justin A Pieper; Edward A Hulten; Edward P Ficaro; James R Corbett; Venkatesh L Murthy; Richard L Weinberg Journal: J Nucl Cardiol Date: 2019-06-24 Impact factor: 5.952
Authors: Benjamin C Lee; Jonathan B Moody; Richard L Weinberg; James R Corbett; Edward P Ficaro; Venkatesh L Murthy Journal: J Nucl Cardiol Date: 2017-05-15 Impact factor: 5.952
Authors: Nabin K Shrestha; Christopher S Ledtke; Hannah Wang; Thomas G Fraser; Susan J Rehm; Syed T Hussain; Gosta B Pettersson; Eugene H Blackstone; Steven M Gordon Journal: Ann Thorac Surg Date: 2014-10-22 Impact factor: 4.330
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Myo Thidar Lwin; Victor Tsoi; Tat Yam; Aisling Carroll; Tony Salmon; Stephen Harden; Lindsay Smith Journal: Eur Heart J Case Rep Date: 2021-03-31
Authors: Sabine Julia Maria Sag; Karin Menhart; Jirka Grosse; Florian Hitzenbichler; Frank Hanses; Arno Mohr; Bernd Salzberger; Matthäus Zerdzitzki; Michael Hilker; Leopold Rupprecht; Dirk Hellwig; Christof Schmid; Lars Siegfried Maier; Can Martin Sag Journal: J Nucl Cardiol Date: 2020-12-22 Impact factor: 3.872